PTGX

PTGX Stockholders Equity

$841.54MQuarterly · USD

Period ending:

PTGX FY Shareholders EquityUSD
PTGX FY Shareholders Equity2014-12-31: $7.96M2015-12-31: $9.60M2016-12-31: -$64.59M2017-12-31: -$101.55M2018-12-31: -$140.47M2019-12-31: $79.96M2020-12-31: $279.61M2021-12-31: $300.02M2022-12-31: $215.61M2023-12-31: $336.68M2024-12-31: $675.30M2025-12-31: $614.71M$675.30M-$140.47M
2014-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

PTGX stockholders equity history

Net worth of the company (assets minus liabilities). The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.

Protagonist Therapeutics Inc Stockholders Equity — Annual fiscal periods (USD)
Period endingStockholders Equity (USD)
614,707,000
675,295,000
336,677,000
215,608,000
300,021,000
279,606,000
79,964,000
-140,474,000
-101,550,000
-64,593,000
9,596,000
7,955,000

Compare stockholders equity

All PTGX financial metrics · PTGX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.